Skip to main content
. Author manuscript; available in PMC: 2011 Dec 2.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4138–4145. doi: 10.1167/iovs.05-1452

Figure 7.

Figure 7

The 20S proteasome inhibitor epoxomicin targets the UPP in HUVECs and HCECs. HUVECs and HCECs were pretreated for 30 minutes with epoxomicin and then stimulated with TNF-α for 20 minutes. Cytoplasmic extracts were analyzed by Western blot for ubiquitin (A, B) and blots reprobed for IκBα expression (C, D). The blots were subsequently reprobed for β-actin to control for protein loading.